Are patterns of cortical hyperexcitability altered in catamenial epilepsy?

Annals of Neurology

Volumn 74, Issue 5, 2013, Pages 743-757

  Badawy, Radwa A B ^a   Vogrin, Simon J ^a   Lai, Alan ^b   Cook, Mark J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Bionics Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ESTROGEN; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PROGESTERONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ANOVULATION; ARTICLE; CATAMENIAL EPILEPSY; CONTROLLED STUDY; CORTICAL HYPEREXCITABILITY; ESTROGEN BLOOD LEVEL; EVOKED MUSCLE RESPONSE; FACILITATION; FEMALE; FOCAL EPILEPSY; FOLLICULAR PHASE; GENERALIZED EPILEPSY; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MOTOR THRESHOLD; NERVE CELL EXCITABILITY; NERVOUS SYSTEM PARAMETERS; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SYNAPTIC INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84890791758     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23923     Document Type: Article

References (56)

1. Klein P, Herzog AG,. Hormonal effects on epilepsy in women. Epilepsia 1998; 39 (suppl 8): S9-S16.
2. Herzog AG,. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure 2008; 17: 151-159.
3. Klein P, van Passel-Clark LM, Pezzullo JC,. Onset of epilepsy at the time of menarche. Neurology 2003; 60: 495-497.
4. Tomson T, Battino D,. Pregnancy and epilepsy: what should we tell our patients? J Neurol 2009; 256: 856-862.
5. Harden CL, Pulver MC, Ravdin L, Jacobs AR,. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40: 1402-1407.
6. Woolley CS,. Estradiol facilitates kainic acid-induced, but not flurothyl-induced, behavioral seizure activity in adult female rats. Epilepsia 2000; 41: 510-515.
7. Scharfman HE, MacLusky NJ,. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006; 47: 1423-1440.
8. Lan NC, Gee KW,. Neuroactive steroid actions at the GABAA receptor. Horm Behav 1994; 28: 537-544.
9. Kokate TG, Svensson BE, Rogawski MA,. Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 1994; 270: 1223-1229.
10. Jacono JJ, Robertson JM,. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 1987; 28: 571-577.
11. Veliskova J,. The role of estrogens in seizures and epilepsy: the bad guys or the good guys? Neuroscience 2006; 138: 837-844.
12. Hoffman GE, Moore N, Fiskum G, Murphy AZ,. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 2003; 182: 124-134.
13. Scharfman HE, Goodman JH, Rigoulota M, et al. Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol 2005; 196: 73-86.
14. Foldvary-Schaefer N, Falcone T,. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 2003; 61 (6 suppl 2): S2-S15.
15. Herzog AG, Fowler KM,. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation. Neurology 2008; 70: 486-487.
16. Herzog AG, Klein P, Ransil BJ,. Three patterns of catamenial epilepsy. Epilepsia 1997; 38: 1082-1088.
17. Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 2004; 56: 431-434.
18. Morrell MJ,. Effects of epilepsy on women's reproductive health. Epilepsia 1998; 39 (suppl 8): S32-S37.
19. Herzog AG, Fowler KM, Sperling MR, et al. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 2011; 52: 1843-1848.
20. Herzog AG,. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure 2008; 17: 101-110.
21. Murri L, Galli R,. Catamenial epilepsy, progesterone and its metabolites. Cephalalgia 1997; 17 (suppl 20): 46-47.
22. Reutens DC, Berkovic SF,. Increased cortical excitability in generalised epilepsy demonstrated with transcranial magnetic stimulation. Lancet 1992; 339: 362-363.
23. Werhahn KJ, Lieber J, Classen J, Noachtar S,. Motor cortex excitability in patients with focal epilepsy. Epilepsy Res 2000; 41: 179-189.
24. Hamer HM, Reis J, Mueller HH, et al. Motor cortex excitability in focal epilepsies not including the primary motor area-a TMS study. Brain 2005; 128 (pt 4): 811-818.
25. Manganotti P, Bongiovanni LG, Zanette G, Fiaschi A,. Early and late intracortical inhibition in juvenile myoclonic epilepsy. Epilepsia 2000; 41: 1129-1138.
26. Badawy RA, Curatolo JM, Newton M, et al. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol 2007; 61: 324-331.
27. Badawy RA, Macdonell RA, Jackson GD, Berkovic SF,. Why do seizures in generalized epilepsy often occur in the morning? Neurology 2009; 73: 218-222.
28. Salih F, Khatami R, Steinheimer S, et al. A hypothesis for how non-REM sleep might promote seizures in partial epilepsies: a transcranial magnetic stimulation study. Epilepsia 2007; 48: 1538-1542.
29. Manganotti P, Bongiovanni LG, Fuggetta G, et al. Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. J Neurol Neurosurg Psychiatry 2006; 77: 56-60.
30. Scalise A, Desiato MT, Gigli GL, et al. Increasing cortical excitability: a possible explanation for the proconvulsant role of sleep deprivation. Sleep 2006; 29: 1595-1598.
31. Badawy RA, Curatolo JM, Newton M, et al. Sleep deprivation increases cortical excitability in epilepsy: syndrome-specific effects. Neurology 2006; 67: 1018-1022.
32. Badawy R, Macdonell R, Jackson G, Berkovic S,. The peri-ictal state: cortical excitability changes within 24 h of a seizure. Brain 2009; 132 (pt 4): 1013-1021.
33. Wright MA, Orth M, Patsalos PN, et al. Cortical excitability predicts seizures in acutely drug-reduced temporal lobe epilepsy patients. Neurology 2006; 67: 1646-1651.
34. Smith MJ, Keel JC, Greenberg BD, et al. Menstrual cycle effects on cortical excitability. Neurology 1999; 53: 2069-2072.
35. Smith MJ, Adams LF, Schmidt PJ, et al. Effects of ovarian hormones on human cortical excitability. Ann Neurol 2002; 51: 599-603.
36. Hattemer K, Knake S, Reis J, et al. Excitability of the motor cortex during ovulatory and anovulatory cycles: a transcranial magnetic stimulation study. Clin Endocrinol (Oxf) 2007; 66: 387-393.
37. Hattemer K, Knake S, Reis J, et al. Cyclical excitability of the motor cortex in patients with catamenial epilepsy: a transcranial magnetic stimulation study. Seizure 2006; 15: 653-657.
38. Badawy RA, Jackson GD, Berkovic SF, Macdonell RA,. Cortical excitability and refractory epilepsy: a three-year longitudinal transcranial magnetic stimulation study. Int J Neural Syst 2013; 23: 1250030.
39. Kwan P, Brodie MJ,. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
40. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077.
41. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994; 91: 79-92.
42. Oldfield RC,. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
43. Cohen JB,. Statistical power analysis for the behavioral sciences. New York, NY: Academic Press, 1969.
44. Di Lazzaro V, Pilato F, Oliviero A, et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. Neurophysiology 2006; 96: 1765-1771.
45. Ziemann U,. Pharmacology of TMS. Suppl Clin Neurophysiol 2003; 56: 226-231.
46. Fedi M, Berkovic SF, Macdonell RA, et al. Intracortical hyperexcitability in humans with a GABAA receptor mutation. Cereb Cortex 2008; 18: 664-669.
47. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471: 501-519.
48. Boroojerdi B,. Pharmacologic influences on TMS effects. J Clin Neurophysiol 2002; 19: 255-271.
49. McDonnell MN, Orekhov Y, Ziemann U,. Suppression of LTP-like plasticity in human motor cortex by the GABAB receptor agonist baclofen. Exp Brain Res 2007; 180: 181-186.
50. Florian J, Muller-Dahlhaus M, Liu Y, Ziemann U,. Inhibitory circuits and the nature of their interactions in the human motor cortex: a pharmacological TMS study. J Physiol 2008; 586: 495-514.
51. Mott DD, Lewis DV,. The pharmacology and function of central GABAB receptors. Int Rev Neurobiol 1994; 36: 97-223.
52. Badawy RA, Macdonell RA, Berkovic SF, Jackson GD,. Cortical excitability and the menstrual cycle: reversal of normal patterns in new onset epilepsy [abstract]. Clin Neurophysiol 2010; 121: S197.
53. Velíšková J, DeSantis KA,. Sex and hormonal influences on seizures and epilepsy. Horm Behav 2013; 63: 267-277.
54. Veliskova J,. Estrogens and epilepsy: why are we so excited? Neuroscientist 2007; 13: 77-88.
55. Smith SS, Shen H, Gong QH, Zhou X,. Neurosteroid regulation of GABA(A) receptors: focus on the alpha4 and delta subunits. Pharmacol Ther 2007; 116: 58-76.
56. Maguire J, Mody I,. Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. J Neurosci 2007; 27: 2155-2162.